ATXN1 has been slow to yield its functions to investigation. It was discovered in 1993 that expansion of its polyglutamine tract produces the adult-onset disease spinocerebellar ataxia type 1, but deletion of the gene in Atxn1 −/− mice results in only mild defects in learning and memory without neurodegeneration [1] [2] [3] [4] [5] . We subsequently discovered that mutant ATXN1 alters the transcription of several neuronal genes 6 , and we searched for protein interactors that contribute to its activities. We found that the transcriptional repressor CIC forms a co-repressor complex (ATXN1-CIC) in vivo with ATXN1 and with its paralog ataxin 1-like (ATXN1L) and that CIC anchors the complex to DNA to repress the target genes of CIC [7] [8] [9] .
by more than 80% die shortly after birth 9, 10 . Atxn1 −/− ; Atxn1l −/− mice exhibit hydrocephalus, an abdominal wall closure defect, and lung defects 9 . Cic-L −/− mice phenocopy Atxn1 −/− ; Atxn1l −/− mice, confirming that these three proteins function as a complex in vivo 9 . Large deletions spanning ATXN1 on chromosome 6p22 have been reported in human patients with autism spectrum disorder (ASD), developmental delay/intellectual disability (DD/ID), seizures, and ADHD [11] [12] [13] , but it is unclear whether the heterozygous loss of ATXN1 or other genes in the deleted region leads to this clinical presentation. In the case of CIC, two different missense mutations have been reported in two isolated cases of intellectual disability 14, 15 , but here again it is unclear whether these variants are causative because there have been no functional studies to confirm the pathogenicity of the reported missense variants in CIC.
We set out to investigate the neurodevelopmental consequences of losing the ATXN1-CIC complex. To bypass the early lethality caused by defects in peripheral organs 9 , we used Cre-loxP technology to generate conditional knockouts of either Atxn1-Atxn1l or Cic. First, we focused our study on the developing forebrain, a region that is known to prominently contribute to the clinical symptoms of individuals with neurodevelopmental disorders 16, 17 , using an Emx1-Cre allele 18 . We discovered that forebrain-specific deletion of ATXN1-CIC caused learning and memory deficits and hyperactivity that responded to a low dose of amphetamine. Conditional knockout neurons in Emx1-Cre mice exhibited histological and cellular defects. Loss of the ATXN1-CIC complex outside of Emx1-Cre domains using the Otp-Cre allele, which is expressed in the hypothalamus and medial amygdala, led to defects in social interaction. Informed by the behavioral phenotypes observed in the mutant mice, we searched for people with truncating mutations in CIC. We found five such individuals with de novo heterozygous truncating mutations in CIC that are predicted to cause nonsensemediated decay of the corresponding transcripts. These individuals present with ASD, DD/ID, seizures, and ADHD, features that overlap with those uncovered in the mouse studies. Altogether, these results demonstrate the necessity of the ATXN1-CIC complex for normal brain development and reveal the region-specific contributions of dysfunctional ATXN1-CIC complex to intellectual disability, hyperactivity, and social-behavioral deficits.
RESULTS

Deleting the ATXN1-CIC complex in the developing forebrain results in multiple behavioral abnormalities
The stable ATXN1-CIC complex is present in many brain regions, including the cerebellum 7, 8 , cortex, and hypothalamus ( Supplementary  Fig. 1 ). Because constitutive knockouts were not viable, we used Cic +/− mice in our initial effort to study the roles of the ATXN1-CIC complex in the brain. In a battery of behavioral tests, Cic +/− mice behaved similarly to their wild-type littermate controls in all of the tests except for the open-field assay, in which they exhibited mild hyperactivity (Supplementary Fig. 2 ). To further study the functions of the ATXN1-CIC complex in the developing brain, we generated conditional knockouts of either Atxn1-Atxn1l or Cic in the developing forebrain through breeding with Emx1-Cre mice, in which the Cre recombinase is expressed in progenitor cells in the dorsal telencephalon starting at embryonic day (E) 10.5 and deletes the conditional alleles in forebrain excitatory neurons and glia 18 . We confirmed the knockout efficiency in the mutant mice by protein blot and immunofluorescent staining, which demonstrated a marked reduction of ATXN1L and CIC protein levels in the Atxn1-Atxn1l and Cic knockouts, respectively ( Supplementary Fig. 3a-c) . Upregulation of the known CIC target genes Etv1, Etv4, and Etv5 in mutant cortex further demonstrated efficient removal of the complex (Supplementary Fig. 3d ).
We performed a series of behavioral tests on the Atxn1-Atxn1l and Cic conditional knockout mouse lines to assess general activity, anxiety, learning and memory, and social behavior. Mice from both lines covered a greater distance at a greater speed in the open-field test than their littermate controls (Fig. 1a,b) . Given the ADHD symptoms in human individuals with deletions spanning ATXN1 (ref. 11) , we tested the effects of a low dose of amphetamine on the Emx1-Cre Cic mutant mice. As has been shown in some ADHD models, low-dose amphetamine treatment exerted a paradoxically calming effect on the mutant animals 19 . Emx1-Cre; Cic flox/flox groups that were treated with vehicle or amphetamine exhibited different baseline activities before drug injection (time points 10-30 min). We reasoned that this was probably due to chance and expected normal variability, as the experimenters were blinded to genotype and treatment. Notably, we found a significant interaction between mouse genotype and drug treatment (Fig. 1c, right) , demonstrating the paradoxically calming effect of a low dose of amphetamine on mutant mice. In the elevated plus-maze test, conditional knockout mice spent more time in the open arm and less time in the closed arm than control mice, possibly as a result of reduced anxiety (Fig. 1d,e) . We used the fear conditioning assay to examine learning and memory in the conditional mutants and discovered that they exhibited reduced freezing, especially in the test of spatial context, indicating that they have impaired learning and memory (Fig. 1f,g ). Finally, we assessed social interaction behavior using the three-chamber test and found that the mutant and control mice behaved similarly ( Supplementary Fig. 4) .
It is worth noting that conditional knockouts of either Atxn1-Atxn1l or Cic displayed similar behavioral deficits, which is consistent with the roles of ATXN1-ATXN1L and CIC as constituents of a protein complex 9 . CIC levels were significantly reduced in tissue from the Atxn1-Atxn1l conditional knockouts, but ATXN1 and ATXN1L levels were not reduced in the Cic conditional knockouts ( Supplementary  Fig. 3a,b) , suggesting that the observed phenotypes in both lines of mutant mice are mostly driven by the loss of CIC functions and disruption of the ATXN1-CIC complex.
Deletion of the ATXN1-CIC complex affects cortical thickness
To determine whether the behavioral deficits in the mutant mice arise from abnormal anatomical development, we examined brain sections from mice aged 5 weeks. We found that the structures of the amygdala and hippocampus were similar in control and conditional Emx1-Cre knockout animals ( Supplementary Figs. 5 and 6) . However, the conditional knockout mice had reduced thickness of cortical layers 2-4, whereas the thickness of layers 5 and 6 remained normal (Fig. 2a,b) . At 20 weeks of age, the amygdala structures remained comparable in the control and mutant mice ( Supplementary Fig. 7a,b) . We observed a similar reduction in the thickness of cortical layers 2-4 in the mutants as was seen at an earlier age, whereas the thickness of layers 5 and 6 in these mice was not affected in comparison to control mice (Supplementary Fig. 7c ). The hippocampal dentate gyrus from conditional knockout mice aged 20 weeks showed decreased thickness, although the thickness of the CA1 and CA3 regions was normal (Supplementary Fig. 7d ). The dentate gyrus is critical for receiving and processing neuronal input from other brain regions, such as the entorhinal cortex, before sending signals to the CA3 region 20 . The pathology in the dentate gyrus in conditional knockout mice, which manifested when the mice were older, might contribute to the learning and memory deficits exhibited by these mice in the contextual fear conditioning test (Fig. 1f,g ). We further examined synapticplasticity in the hippocampus and found that, although basal synaptic transmission and long-term synaptic plasticity were preserved in the Emx1-Cre Cic knockout mice, there was a decrease in the probability of presynaptic neurotransmitter release (Supplementary Fig. 8 ).
We next examined the cortex using markers specific to layers 2-4 (CUX1), layers 5 and 6 (CTIP2; also known as BCL11B), and layers 2-6 (SATB2). In accordance with the Nissl staining results, the number of CTIP2 + cells remained unchanged in the conditional knockout mice (Fig. 2c,d) . Although the number of SATB2 + neurons in layers 2-4 was only slightly reduced in comparison to control mice, the number of CUX1 + neurons in layers 2-4 was dramatically reduced in the knockout mice (Fig. 2c,d ). Among control neurons in layers 2-4, most SATB2 + cells coexpressed CUX1; in contrast, only half of SATB2 + cells in layers 2-4 were CUX1 + in the knockouts (Fig. 2d) . These findings suggest that the reduction in the number of CUX1 + cells is primarily driven by loss of CUX1 expression in neurons from layers 2-4. In support of this hypothesis, Cux1 expression was reduced in the mutant cortex (Supplementary Fig. 9a ). However, the expression level of Cux2, which is a paralog of Cux1 and a marker for pyramidal neurons in layers 2-4, was unaffected in the mutant cortex, suggesting that there is no global defect in the fate of neurons from layers 2-4 ( Supplementary Fig. 9b ). Because the majority of callosal projection neurons (CPNs) reside in the upper cortical layers and the projections of CPNs form the corpus callosum 21 , we examined the formation of the corpus callosum with Luxol fast blue, which stains myelin. The formation of the corpus callosum was not disrupted in mutant brains, nor was the thickness of the corpus callosum significantly different than in control brains (Supplementary Fig. 10 ). Because Atxn1-Atxn1l conditional mutants phenocopied Cic conditional mutants, we focused on the Cic conditional mutants to further dissect the cortical defects resulting from loss of function of the complex.
One possible explanation for the observed reduction in the number of neurons in layers 2-4 is defective progenitor proliferation. To address this possibility, we first assessed whether CIC is expressed in progenitor cells of the embryonic cortex and found this to be the case (Supplementary Fig. 11a ). As neurons in layers 2-4 are generated primarily around E14.5-E16.5 in mice 22 , we assessed the proliferation of the cortical progenitors at E14.5 and E16.5 through 2-h pulse labeling with the thymidine analog EdU (ethynyl-2´-deoxyuridine). By combining EdU labeling with that for specific markers (TBR2 for intermediate progenitors and PAX6 for radial glia), we found that the numbers of progenitors and their proliferation rates (estimated from cells that were double positive for EdU and specific markers) were not different in mutant as compared to wild-type cortex (Supplementary Fig. 11b) .
We next hypothesized that the reduction in the number of CUX1 + cells in mutant cortex is due to postnatal defects in neuronal maturation or maintenance. The numbers of CUX1 + and SATB2 + neurons in layers 2-4 in mutant cortex were similar to those in control cortex at postnatal day (P) 0, but the numbers in the mutant cortex declined postnatally and, by P10, were comparable to those of animals aged 5 weeks (Fig. 3a) . Furthermore, we generated conditional Cic knockout mice using the Neurod6-Cre (NEX-Cre) allele, which has a spatiotemporal expression pattern similar to that of Emx1-Cre but is selectively expressed in postmitotic excitatory neurons 23 . When we examined the cortex in Neurod6-Cre conditional mutant mice, we still observed a reduction in In all other panels, statistical analyses were performed with one-way ANOVA with Holm-Sidak's post hoc test. The exact number of animals for each genotype is shown in parentheses. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.
A r t i c l e s the number of cells expressing CUX1 and SATB2 in layers 2-4 ( Fig. 3b) . These experiments suggest that the reduction in the numbers of CUX1-and SATB2-expressing cells is caused by defects in postmitotic neurons in the cortex of mutant mice. Increased apoptosis of upper-layer neurons is a potential explanation for the postnatal decline in the number of SATB2 + cells in cortical layers 2-4 of mutant mice. To address this possibility, we monitored cell death in the cortexes of P5 and P10 mutant mice using immunostaining for activated caspase-3 (CASP3). We found more CASP3 + cells in the upper layers of the cortex of Emx1-Cre mutant mice at P5 than in control mice, whereas the numbers of CASP3 + cells were similar in the cortexes of mutant and control mice at P10 (Supplementary Fig. 12) . These results suggest a transient upregulation of apoptosis in the upper layers of the cortex of P5 mutant mice, which is consistent with the observed initial decline in the number of SATB2 + cells in layers 2-4 of mutant mice at P5.
CIC is critical for neuronal dendritic branching
Because CUX1 has roles in promoting dendritic branching 24, 25 and CUX1 levels were reduced in the mutant cortex, we set out to examine the dendritic morphology of layer 2/3 neurons. To this end, we sparsely labeled neurons from P0 mice by injecting the mice with low-titer adeno-associated virus (AAV) encoding yellow fluorescent protein (YFP) 26 . We dissected brains when the animals were 5 weeks old and examined the dendritic branching patterns of pyramidal neurons. Using Sholl analysis, we discovered that the layer 2/3 pyramidal neurons of mutant mice displayed significantly reduced dendritic branching complexity as compared to controls Statistical analyses were performed using two-tailed t-tests.*P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.
( Fig. 4a) . The dendritic branching complexity of layer 5 pyramidal neurons did not differ in mutant and control animals ( Fig. 4b) .
Deleting Cic in the hypothalamus and medial amygdala causes abnormal social interaction in mice Next, we explored the neurobehavioral consequences of deleting the ATXN1-CIC complex outside of the Emx1 expression domain. We used a Cre line that targets deletion to hypothalamic and medial amygdala neurons using the promoter from Otp (orthopedia homeobox) 27, 28 . Using the ROSA26 fsTRAP reporter line to label Cre + cells 29 ,
we found that Cre was expressed in the medial amygdala (MeA) and multiple hypothalamic regions, including the paraventricular nucleus (PVN), supraoptic nucleus (SON), and lateral hypothalamic area (LHA), as well as the dorsomedial and ventromedial hypothalamic nuclei (DMH and VMH) ( Supplementary Fig. 13 ). The expression pattern of Otp-Cre was consistent with the endogenous expression pattern of Otp, covering neuroendocrine neurons (for example, in the PVN and SON) as well as regions that underlie social and emotional responses (VMH and MeA) 27, [30] [31] [32] . We then generated Otp-Cre Cic conditional knockout mice and validated the knockout efficiency of 
A r t i c l e s
Cic by confirming that the protein levels of CIC were greatly reduced in Cre + cells (Supplementary Fig. 14a ).
To investigate whether CIC functions in Otp-lineage neurons to modulate neurobehavior, we performed a battery of behavioral tests. The Otp-Cre conditional mutant mice showed distinct behavioral defects in comparison to Emx1-Cre conditional mutants. The Otp-Cre conditional knockouts did not exhibit abnormal behavior in the open-field, elevated plus-maze, or fear conditioning assay ( Fig. 5a and Supplementary Fig. 15 ), but they did show prominent social interaction deficits. In the three-chamber test, the conditional knockout mice interacted less with other mice than the control mice did (Fig. 5b) . In the partition test, the conditional knockout mice spent less time interacting with novel mice, while Otp-Cre; Cic flox/+ mice showed an intermediate phenotype (Fig. 5c) . In the residentintruder test, the conditional knockout mice behaved more aggressively toward intruders, with more frequent and longer attack episodes than those observed for controls (Fig. 5d) . These results suggest that CIC has important functions in the MeA and hypothalamus to modulate social interaction.
In contrast to the pronounced cortical layering defects in Emx1-Cre knockout animals, we did not observe any gross histological abnormalities or altered cellularity for Otp-lineage neurons in Otp-Cre conditional mutants (Supplementary Figs. 14b and 16) . The expression levels and patterns of several hypothalamic nucleus markers were also unaltered in mutant mice ( Supplementary  Fig. 17) . Next, because CIC is a transcriptional regulator, we examined gene expression profiles in Otp-lineage neurons to investigate the molecular changes leading to the social interaction deficits in Otp-Cre mutant mice. To isolate RNA specifically from these neurons, we applied the translating ribosome affinity purification (TRAP) approach using the Cre-dependent ROSA fsTRAP mouse line 29 in which ribosomes are tagged with GFP in Cre-expressing cells. TRAP and RNA isolation were performed when animals were aged 8-10 weeks 33 . RNA-seq and gene expression analysis showed that a total of 207 genes were differentially expressed between Otp-Cre; Cic flox/ flox ; ROSA fsTRAP and Otp-Cre; ROSA fsTRAP neurons, with 123 genes upregulated and 84 genes downregulated (false discovery rate (FDR) < 0.05; Supplementary Fig. 18 and Supplementary Table 1 ). The known CIC targets Etv4 and Etv5 were among the most upregulated genes. Gene set analysis showed that differentially expressed genes were significantly enriched for genes involved in abnormal nervous system morphology, abnormal synaptic transmission, and abnormal social or conspecific interaction (adjusted P < 0.05; Fig. 5e) . Notably, ten genes associated with abnormal synaptic transmission and eight genes associated with abnormal social or conspecific behavior showed a more than 1.5-fold difference in expression between the two lines (Supplementary Table 2 ). We further validated the expression differences for a subset of genes from each group using quantitative real-time PCR (Supplementary Fig. 19) . Dysregulation of the expression of these genes might contribute to the social-behavioral deficits observed in the Otp-Cre mutant mice.
CIC mutations cause a human neurodevelopmental syndrome
Prior to our study, it was unclear whether loss-of-function mutations in ATXN1 and CIC cause neurodevelopmental disorders because no isolated, truncating alleles had been identified for either gene. Our studies showed that the ATXN1-CIC complex has critical roles in brain development that affect behavior and that ATXN1 and A r t i c l e s ATXN1L execute their functions mainly through forming a complex with CIC. Guided by this knowledge and our prediction that homozygous loss-of-function mutations in CIC would lead to premature lethality, we sought to identify individuals with heterozygous loss-of-function mutations in CIC. It is also worth noting that lossof-function mutations in CIC are predicted to be highly intolerable by the Exome Aggregation Consortium (ExAC) database (probability of loss-of-function intolerance (pLI) = 1.00; version 0.3.1) 34 . Although a g.42796882G≥GC loss-of-function variant on chromosome 19 was reported in multiple individuals in the ExAC database, we found that the high frequency of this variant probably arose from sequencing and/ or reporting errors or from low-grade mosaicism in the individuals The exact number of animals for each genotype is shown in parentheses. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.
A r t i c l e s with the variant. Thus, the occurrence of this variant does not contradict the prediction of intolerance to loss-of-function mutations from ExAC and our genetic findings below. Through collaborative efforts, we identified four individuals from three families with heterozygous de novo truncating mutations in CIC and one individual with a nonsense variant inherited from a father who is a low-grade mosaic for the variant (Fig. 6a,b) . Individuals 1 and 2-2 were part of exome trios. Additionally, we performed whole-exome sequencing on individual 2-1. Individuals 3 and 4 were sequenced by whole-exome sequencing with the de novo nature of the variants confirmed by targeted Sanger sequencing of the parents. The CIC variants in all affected individuals were confirmed by Sanger sequencing. Besides the CIC variants, no variants were identified in known disease-causing genes that accounted for the clinical phenotypes. The five individuals had presented clinically with a spectrum of phenotypes, including DD/ID, ADHD, ASD, and seizures ( Table 1 and Supplementary Note).
Family 2 was notable for having two siblings who were apparently affected; subsequent interrogation of the mutant allele in all six members of family 2 by Sanger sequencing found that the genotype segregated faithfully with the phenotype, suggesting germline mosaicism for the mutant allele in one of the parents (Supplementary Fig. 20) . The father in family 4 is mosaic for the mutant allele (~15% mosaicism). By investigating the mutant allele in all family members using Sanger sequencing, we found that only the proband is heterozygous for the mutant allele, whereas the two unaffected brothers have only the wildtype allele (Supplementary Fig. 21 ). We examined fibroblasts derived from patient 1 and found that both the protein and RNA levels of CIC were reduced to almost 50% of those in control fibroblasts (Fig. 6c,d and Supplementary Fig. 22 ), supporting the idea that the mutation in patient 1 leads to nonsense-mediated decay and causes loss of function at the protein level.
DISCUSSION
In this study, we examined the roles of the ATXN1-CIC complex in the developing nervous system and discovered a cell-type-and region-specific role for this complex in neurobehavioral functions. First, within the cortex, the ATXN1-CIC complex is more important for upper-layer neurons. Although CIC is expressed in all cortical layers and the protein was effectively removed from all layers in Emx1-Cre conditional knockouts, reduction of cortical thickness and cellular morphological defects were evident in the upper cortical layers, whereas the lower layers appeared intact. One explanation is that the ATXN1-CIC complex might have distinct downstream target genes in different cortical layers; it is also possible that other transcription factors compensate for the loss of CIC in lower cortical layers. There has been rapid advancement in single-cell transcriptomic technologies, and studying the transcriptomic changes in different cell types at specific time points may provide insight into the possible mechanisms for the selective phenotype we observed.
The upper-layer defects observed in Emx1-Cre conditional mutants are most likely driven by defects in postnatal maturation or maintenance of these neurons, as reduction in the number of SATB2 + neurons was evident only after P5. This is further supported by our analyses of Neurod6-Cre conditional knockout mice, which suggest that the reduction was due to defects in postmitotic neurons but not in their fate specification. At P5, we observed a transient increase in the number of neurons undergoing apoptosis in layers 2-4 of Emx1-Cre mutant cortex, which could contribute to the postnatal reduction of SATB2 + cells in layers 2-4. In addition, SATB2 + cells in layers 2-4 from the cortexes of mutant mice also expressed less Cux1 RNA and protein.
The underlying mechanism leading to reduction of CUX1 expression remains elusive, but evidence suggests that CUX1 dosage is important for maintaining the dendritic morphology of cortical neurons. Layer 2/3 neurons from Cux1 −/− mice show fewer dendritic branches and spines 24 , whereas overexpression of Cux1 in cultured cortical neurons increases spine density 25 . Therefore, in our studies, reduced CUX1 levels in the cortex of Emx1-Cre mutants could contribute to the observed dendritic arborization defects of the upper-layer neurons. Very recently, homozygous mutations in a human accelerated region that could increase the expression of CUX1 were identified in patients with ASD and intellectual disability 25 . Our findings resonate with previous studies and highlight the importance of CUX1 dosage in modulating cognitive and social behavior outcome.
In some patients with ADHD, brain imaging studies have identified cortical abnormalities 16 , and there is also a reduction in cortical thickness and a marked delay in maturation across different brain regions 35, 36 . Our Emx1-Cre conditional mutant mice provide evidence for the potential consequences of disrupting upper cortical layers, including hyperactivity and learning-deficit phenotypes. This provides an exciting opportunity to understand the contribution of A r t i c l e s specific cortical circuit defects to the clinical phenotypes of people with ADHD. Upper-layer neurons project axons that contribute to the corpus callosum, but the formation and thickness of the corpus callosum were unaffected in Emx1-Cre mutant mice. This suggests that the formation of long-range projections by upper-layer neurons is anatomically normal, but it remains possible that these neurons are functionally compromised. Although Emx1-Cre conditional mutants recapitulated the hyperactivity and learning and memory deficits seen in patients with heterozygous loss of CIC, Otp-Cre knockout mice displayed phenotypes resembling ASD. The VMH nuclei and MeA, which both contain Otp-lineage neurons, are activated in both aggressive and affiliative behavior 31, 32 . Misexpression of genes that influence synaptic transmission and social interaction might interfere with synaptic plasticity and disrupt social brain circuits at the cellular level. For example, the expression of Shank3, which encodes a dosage-sensitive synaptic scaffold protein whose dysfunction is involved in human neuropsychiatric disorders, is significantly reduced in Otp-Cre mutant neurons. In Otp-Cre mutant neurons, the combinatorial effects of expression changes in Shank3 and other dysregulated genes that have reached their dysfunction thresholds might compromise healthy neuronal activity under social stimuli. Although the Emx1-Cre and Otp-Cre conditional knockouts together reproduced many clinical features of patients with loss-of-function mutations in CIC, we did not observe overt seizures in any of our mutant mice by visual examination (Cic +/− mice, Emx1-Cre mutants, or Otp-Cre mutants). Also, we did not find any abnormalities in electroencephalograms during two 8-h recordings from Cic +/− mice or Emx1-Cre mutants (data not shown). However, we have observed seizures in Cic-L −/− mice on a highly mixed background (H.Y.Z., personal observation). It is possible that seizures in patients arise from dysfunction of forebrain inhibitory neurons, which correspond to a type of cells in which Emx1-Cre is not expressed. Future studies with additional Cre drivers can help pinpoint the cell types responsible for seizures and elucidate possible underlying mechanisms.
In conclusion, studying the roles of the ATXN1-CIC complex in the mouse brain has led us to identify new mutations underlying neuropsychiatric disease in humans. Our findings highlight distinct brain regions underlying the clinical symptoms in affected individuals and provide tractable models to further dissect the circuitries contributing to ADHD, learning deficits, and social behavior abnormalities. Our strategy underscores the value of model organisms in uncovering new syndromes and their pathophysiology. It is the findings in Emx1-Cre-and Otp-Cre-driven Cic-deletion mice that led us to search for individuals with loss-of-function mutations in CIC and informed us of the breadth of CIC haploinsufficiency manifestations. Two-way research between mouse models and humans continues to uncover the neuronal and molecular bases of complex neurobehavioral disorders.
METHODS
Methods, including statements of data availability and any associated accession codes and references, are available in the online version of the paper. 
ONLINE METHODS
Human subjects. Patients were identified either by direct contact with the family (family 1) or connections through GeneMatcher (families 2-4) 37 . Individuals 1 and 2-2 were part of exome trios (the proband plus two biological parents). Individual 2-1 was subsequently enrolled in a whole-exome sequencing study, and her results were compared with those of the parents and individual 2-2. Probands 3 and 4 were sequenced by whole-exome sequencing, with de novo variants confirmed through targeted Sanger sequencing of the parents. The CIC variants in all affected individuals were confirmed by Sanger sequencing. Buccal swab DNA from the three siblings of patient 2-2 was sent from GeneDx to the lab of H.Y.Z. for testing of CIC variants using Sanger sequencing. Fibroblasts from patient 1 were generated by the lab of R.H.F. Families 1 and 2 were enrolled under a research protocol approved by the Institutional Review Board of Baylor College of Medicine. Family 3 was enrolled under a research protocol approved by the Institutional Review Board of Mayo Clinic. All individuals or their guardians consented to participation in publication.
Statistical tests. Statistical tests were performed with GraphPad Prism. The details of the statistical tests and results are reported in Supplementary Table 3 . For behavioral tests, values in all groups were assumed to be normally distributed. Welch's correction was used for t-tests when variances between groups were significantly different by F-test. The Geisser-Greenhouse correction was used for one-way ANOVA.
DNA Sanger sequencing of the proband's siblings in family 2. Buccal swab DNA samples in NaOH were retrieved from GeneDx, and PCR was performed using these samples. After PCR, the products that were amplified from the DNA of the two unaffected siblings were purified and then underwent Sanger sequencing. A-tails were added to the PCR products amplified from the affected sibling's DNA using Taq polymerase, and the sequences were ligated into pGEM-T Easy vectors (Promega). The ligation mixture was transformed into DH5α Escherichia coli, and colonies were isolated followed by plasmid purification (NucleoSpin, Macherey Nagel).
Mouse models. All procedures in mice were approved by the Institutional Animal Care and Use Committee of Baylor College of Medicine. Atxn1-null 3 , Atxn1l flox9 , Emx1-Cre 18 , Neurod6-Cre 23 , and ROSA fsTRAP29 mice have been described previously. To generate the Otp-Cre allele, a BAC containing Otp (RP24-337G4) was modified using recombineering to replace the Otp coding sequence with Cre 38 . The modified BAC DNA was isolated and digested with BsiWI to release the transgene for pronuclear injection. Pups derived from the microinjected embryos were screened for the presence of the transgene. Transgenic founders were then mated to wild-type FVB mice, and the offspring were screened for germline transmission. Transgenic mice with germline transmission were then backcrossed to the C57BL/6 background for more than seven generations.
Generation of Cic flox and Cic null alleles was carried out as follows. Embryonic stem (ES) cells with the Cic tm1a(KOMP)Wtsi allele were obtained from EUCOMM and were injected into C57BL/6 blastocysts. Cic flox mice were then generated by breeding to ACTB:FLPe mice to remove the gene-trap cassette, and the Cic null allele was generated by crossing to CMV-Cre mice ( Supplementary  Fig. 23 ). All mice were maintained on a C57BL/6 background. The day of plug observation was denoted E0.5 for timed-pregnant experiments. Primers for genotyping are reported in Supplementary Table 4 . Both males and females were used, and we did not observe any difference between the sexes in the phenotypes.
Antibodies. The following primary antibodies were used for protein blotting: rabbit polyclonal anti-ATXN1 (1:5,000; ref.
2), rabbit polyclonal anti-ATXN1L (1:5,000) 8 , mouse monoclonal anti-VCL (1:10,000; Sigma, V9131), mouse monoclonal anti-GAPDH (1:10,000; Advanced ImmunoChemical, 2-RGM2), and guinea pig polyclonal anti-CIC (1:5,000) 7 . The primary antibodies used in immunofluorescence studies were as follows: rabbit anti-CUX1 (1:50; Santa Cruz, sc-13024), rat anti-CTIP2 (1:500; Abcam, ab18465), mouse anti-SATB2 (1:100; Abcam, ab51502), rabbit anti-CIC (1:2,000; generated in house using the antigen described in ref. 7) , rabbit anti-PAX6 (1:250; Covance, PRB-278P), rabbit anti-TBR2 (1:300; Abcam, ab23345), chicken anti-GFP (1:2,000; Abcam, ab13970), and rabbit anti-CASP3 (1:500; Cell Signaling Technology, 9661). Rabbit anti-CIC was validated in this study (Supplementary Fig. 3 ). Other antibody validation is provided on the manufacturer's website.
Behavioral tests.
The open-field test, elevated plus-maze test 39 , low-dose amphetamine treatment 40 , and fear conditioning 41 were performed as previously described. The three-chamber test was performed as previously described 39 with the following modifications: ambient light was maintained at 700-800 lx and white noise was used. The partition test was performed as previously described 39 with the modification that test mice were individually housed in standard housing cages separated into two compartments by a clear perforated Plexiglas barrier for 1 d. The resident-intruder test was performed as previously described 39 with the modification that male mice were singly housed for 4 weeks before testing to establish dominance. Tests were videorecorded, and the episodes and duration of attacks were analyzed.
The novel object recognition test was performed with the following protocol. During habituation, the test mouse was placed in the habituation arena and allowed to explore for 30 min. Following habituation, the test mouse was introduced into the test arena where two identical objects (Legos) were placed with equal distance to the walls of the arena. The test mouse was allowed to explore the arena for 5 min (trial 1). After the first trial, the test mouse was returned to the habituation arena, and the test arena and objects were cleaned with ethanol. On trials 1-3, identical objects were placed in the arena for the test mouse to explore and become familiar with. On trial 4, a novel object, which was a Lego with a different color and shape than the familiar objects, was introduced into the test arena to replace one of the familiar objects. The test mouse was then allowed to explore the arena for 5 min. On trial 5, the familiar object replaced the novel object and the test mouse was reintroduced back into the test arena. The amount of time that the test mouse spent on investigating (sniffing, climbing, and touching) the objects was recorded using the AnyMaze video tracking system. The test mouse was allowed to rest for at least 10 min between each trial.
Sample size in the behavioral studies was estimated on the basis of our previous experience with these behavioral tests. All behavioral tests were performed with the investigators blinded to the genotypes or treatment. In the low-dose amphetamine treatments, mice were assigned to either vehicle or amphetamine treatment using a list randomizer. Five animals were excluded from the drug treatment because an inadvertent cage change on the same day prior to test administration disturbed the baseline behavior of the mice. No other animals were excluded from other tests.
Hippocampal slice preparation and electrophysiology. Mice were anaesthetized by isoflurane inhalation and decapitated. The brain was isolated and immersed in chilled (2-5 °C) cutting solution containing 220 mM sucrose, 2.5 mM KCl, 0.5 mM CaCl 2 , 7 mM MgCl 2 , 1.25 mM NaH 2 PO 4 , 25 mM NaHCO 3 , and 7 mM d-glucose. Transverse hippocampal slices (400 µm) were prepared with a vibratome (Leica Microsystems). The slices were incubated at 37 °C for 30 min in artificial cerebrospinal fluid (ACSF) containing 125 mM NaCl, 2.5 mM KCl, 2 mM CaCl 2 , 1 mM MgCl 2 , 1.25 mM NaH 2 PO 4 , 25 mM NaHCO 3 , and 14.83 mM d-glucose. They were then transferred to room temperature for another 30 min before recording.
Extracellular stimuli were administered along the Schaffer collaterals using a bipolar tungsten stimulation electrode (WPI), and field excitatory postsynaptic potentials (fEPSPs) were recorded in stratum radiatum. The recording pipettes were filled with 2 M NaCl (1-2 M), and their distance to the stimulating electrode was kept constant (~300 µm). Input/output (I/O) curves were generated using incremental stimulus intensities and were used to assess baseline synaptic transmission. All subsequent stimuli were set to an intensity that evoked 30-40% of the maximum fEPSP slope. Paired-pulse facilitation was assessed via systematic stimuli with different intervals (25, 50, 100, 200 , and 400 ms). The paired-pulse ratio was obtained by dividing the rising slope of the second fEPSP by the rising slope of the first fEPSP. For long-term potentiation (LTP) experiments, stable baseline fEPSPs were recorded for 20 min and LTP was then induced by two trains of high-frequency stimulation (HFS; 100 Hz for 1 s) with a 20-s interval between trains. The magnitude of potentiation was determined by measuring the rising slope of the fEPSP.
The recordings were acquired using Multiclamp 700B amplifiers (Molecular Devices). Data acquisition and analysis were performed using digitizer DigiData 1440A and analysis software pClamp 10 (Molecular Devices). Signals were filtered at 2 kHz and sampled at 10 kHz. All recordings were performed at 30 ± 1 °C by using an automatic temperature controller (Warner Instrument).
Coimmunoprecipitation. The cortex or hypothalamus was dissected from a wild-type mouse aged 8 weeks and homogenized in 500 µl of extraction buffer (75 mM NaCl, 5 mM MgCl 2 , 50 mM Tris pH 8.0, 0.5% Triton X-100, supplemented with fresh protease inhibitors and phosphatase inhibitors). The homogenates were then centrifuged at 16,000g for 15 min at 4 °C. The supernatants were diluted five times using the extraction buffer without any detergent. For each immunoprecipitation, 20 µl of prepared Dynabeads Protein A (Novex, Life Technology) was added to 500 µl of the diluted extract, together with 1 µl of rabbit anti-CIC antibody or normal rabbit IgG. Immunoprecipitation reactions were performed overnight at 4 °C with gentle head-to-tail rotation. The beads were then washed three times with the extraction buffer (with detergent), and proteins bound to the beads were eluted with SDS sample loading buffer. Coimmunoprecipitation samples were analyzed by protein blot.
Column fractionation and analysis. Gel filtration (sizing) chromatography was performed as previously described 42 using the cortex or hypothalamus from five animals aged 8 weeks. For each column chromatography, 4 mg of total protein was loaded to the column for analysis.
Histology. Samples were dissected and fixed in 4% paraformaldehyde in PBS or 10% neutral-buffered formalin for 24-48 h. The tissues were then incubated in 70% ethanol for 24 h, 95% ethanol overnight, 100% ethanol for 4 h, chloroform overnight, and paraffin twice for 4 h each time. The tissues were then embedded in paraffin and sectioned at a thickness of 8 µm. Nissl (cresyl violet) staining and Luxol fast blue staining were performed using standard protocols.
Immunofluorescence staining and TUNEL assays. For Emx1-Cre and Neurod6-Cre studies, animals were anesthetized and transcardially perfused with 4% paraformaldehyde in PBS. Tissues were collected and fixed in 4% paraformaldehyde in PBS at 4 °C overnight. The tissues were cryoprotected in 15% and 30% sucrose in PBS, and were then imbedded and frozen in TissueTek OCT compound. Tissues were sectioned at a thickness of 25 µm, mounted on Superfrost Plus microscope slides, and air-dried, followed by rehydration in PBS. For Otp-Cre studies, brain tissues were directly frozen in Tissue-Tek OCT compound, sectioned at a thickness of 25 µm, and mounted on Superfrost Plus microscope slides. Prior to staining, the slides were fixed in 10% neutralbuffered formalin for 15 min and washed three times with PBS. All slides were blocked in blocking buffer at room temperature for 1 h, followed by incubation with primary antibodies in blocking buffer at 4 °C overnight. The slides were washed with 0.1% Triton X-100 in PBS three times and incubated with secondary antibodies in blocking buffer at room temperature for 2 h. The slides were then washed with 0.1% Triton X-100 in PBS two times, counterstained with DAPI, washed with 0.1% Triton X-100 in PBS once, and washed with PBS once. Slides were mounted with coverslips with ProLong Gold or ProLong Diamond (Molecular Probes). When needed, antigen retrieval was performed before blocking using Antigen Unmasking Solution (Vector Laboratory, Citric Acid Based) at 95 °C for 20-60 min and slides were cooled for at least 20 min at room temperature. The slides were then washed in PBS three times and blocked and stained as described above.
TUNEL assays were performed using the Click-iT Plus TUNEL assay kit (with Alexa Fluor 488 dye, Molecular Probes) with minor modifications: 25-µm-thick, air-dried cryosections mounted on slides were used for the assay; in addition to the proteinase K treatment recommended by the manufacturer, an additional 700 µg of proteinase K (at 1 mg/ml) was added to each slide and the slides were incubated for 70 min at room temperature; and after the TUNEL assay, the sections were counterstained with DAPI.
EdU labeling. EdU (50 mg per kg body weight; Santa Cruz, sc-284628) was injected intraperitoneally into timed-pregnant female mice. Two hours later, injected mice were euthanized, and embryonic brains were dissected and fixed overnight. The tissues were then cryoprotected and sectioned as described in "Immunofluorescent staining". EdU was labeled with the Click-iT EdU Alexa Fluor Imaging kit (Thermo) before immunofluorescent staining.
Image acquisition and analysis. Confocal images were acquired with a Leica TCS SP8 or ZEISS LSM 880 microscope. Epifluorescence images were acquired with a Leica DM4000 microscope. Light microscopy images were acquired with a Leica DM4000 or Zeiss Axio Scan.Z1 slide scanner. For cell counting, images from parietal cortices were cropped into 200-µm bins and cells were quantified with Fiji using the Cell Counter plugin 43 . The thickness of the pyramidal layers of CA1 and CA3, as well as the thickness of the granule layer of the dentate gyrus, was measured using Fiji. All analyses were performed with the experimenter blinded to genotype.
Dendritic branching analysis. AAV-YFP (AAV8 with CBA-YFP-2A-YFP-2A-YFP) was generated and injected into lateral ventricles as previously described 26 . To achieve sparse labeling, 4.8 × 10 7 viral particles were injected into each ventricle. At 5 weeks of age, the animals were anesthetized and transcardially perfused with 4% paraformaldehyde in PBS. Brains were collected and fixed in 4% paraformaldehyde in PBS at 4 °C overnight. 100-µm sections were obtained with a Leica vibratome. The sections were mounted on Superfrost Plus microscope slides and coverslipped with VECTASHIELD (Vector Laboratories). Pyramidal neurons were identified based on their morphology and location. z-stack images were taken with a ZEISS LSM 880 microscope. Neuronal structure reconstruction and Scholl analysis were performed with Neurolucida 360 software (MBF Bioscience).
In situ hybridization. RNA in situ hybridization was performed on adult mouse brain sections. The DNA templates for the in situ hybridization probes were amplified from mouse brain cDNA and cloned into pGEM-T Easy vectors. To generate DIG-labeled mRNA probes in vitro, transcription was performed using a kit from Roche according to the manufacturer's instructions. The primer sequences and further information about the probes are provided in Supplementary Table 4 . Adult mouse brains were collected and immediately embedded and frozen in Tissue-Tek OCT compound. Coronal sections were collected from the somatosensory cortex at 25-µm thickness. In situ hybridization was performed as previously described 44 , and the stained slides were imaged using a Zeiss Axio Scan.Z1 slide scanner.
Quantitative RT-PCR. RNA was extracted with TRIzol and reverse transcribed using M-MLV reverse transcriptase (Thermo). Real-time PCR was performed with PerfeCTa SYBR Green FastMix ROX (Quanta Biosciences) or iTaq Universal SYBR Green (Bio-Rad). Primers are listed in Supplementary  Table 4 . Rps16 was used as the reference gene, and fold changes were calculated using the 2 −∆∆C T method 45, 46 . In short, the mean of the threshold cycle (C T ) of three technical replicates was used as the C T value for a given animal.
generated. For validation, real-time PCR was performed with iTaq Universal SYBR Green (Bio-Rad). Primers are listed in Supplementary Table 4 . Rps16, Hprt, and Gapdh were used as reference genes, and fold changes were calculated using the 2 −∆∆C T method 45, 46 .
RNA-seq data analysis. For each sample, about 100 million pairs of 100-bp pair-end reads were generated. Raw reads were trimmed before mapping to the reference genome. Trimmed reads were then aligned to the Mus musculus genome (UCSC mm10) using TopHat v2.0.9 (ref. 47 ) with default parameters. The mappability for all eight samples was about 50%. HTSeq 48 was used to obtain read counts. Using the obtained read counts, differential gene analysis was carried out using the DESeq package in the R environment. A gene was identified as showing a significant change in expression if it fell under the FDR threshold of 5%. Phenotype association analyses were performed using the WebGestalt Toolkit 49, 50 .
Data availability. The gene expression data that support the findings of this study are available in the GEO (Gene Expression Omnibus) repository with accession GSE83243.
